**Core Concept**
Multiple myeloma is a type of plasma cell malignancy characterized by the proliferation of malignant plasma cells in the bone marrow. Metabolic abnormalities in multiple myeloma are often related to the excessive production of monoclonal immunoglobulins, which can disrupt normal metabolic pathways.

**Why the Correct Answer is Right**
The correct answer is related to the hypercalcemia seen in multiple myeloma. Hypercalcemia occurs due to the excessive bone resorption by osteoclasts, which is stimulated by the production of various cytokines and growth factors, including parathyroid hormone-related protein (PTHrP) and prostaglandins. These factors act on osteoclasts to increase bone resorption, leading to the release of calcium ions into the bloodstream.

**Why Each Wrong Option is Incorrect**
* **Option A:** Hyperkalemia is not typically associated with multiple myeloma. Elevated potassium levels are more commonly seen in conditions such as renal failure or Addison's disease.
* **Option B:** Hypocalcemia is not characteristic of multiple myeloma. While hypercalcemia is a common feature, hypocalcemia is more typically seen in conditions such as hypoparathyroidism or vitamin D deficiency.
* **Option C:** Hypophosphatemia is not a direct consequence of multiple myeloma. While phosphate levels may be affected in some cases, it is not a primary metabolic abnormality associated with this condition.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that hypercalcemia in multiple myeloma is often resistant to treatment with calcitonin or bisphosphonates, and may require more aggressive management, such as glucocorticoids or zoledronic acid.

**Correct Answer: D. Hypercalcemia**